CClinicalTrials.gg
Status unknownNCT02731547Updated Apr 13, 2016

Education Against Tobacco Randomized Trial in Bosnia and Herzegovina

An interventional study of Education Against Tobacco School-Based Intervention in Tobacco Prevention, Tobacco and Schools, sponsored by University of Giessen. Status unknown. Open to participants aged 10 Years to 20 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-04-13.

Sponsored by University of Giessen · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Apr 2016), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
1,500
Allocation
Randomized
Ages
10 Years to 20 Years
Sex
All
01

Study summary

A two armed randomized trial is evaluating the effect of the medical-student-delivered school-based intervention Education Against Tobacco on the smoking behavior of adolescents in 7-11th grade of secondary schools in Bosnia and Herzegovina. The primary endpoint is the change in smoking prevalence between the two groups.

02

Conditions studied

  • Tobacco Prevention
  • Tobacco
  • Schools
03

In context

Lead sponsor

University of Giessen is the lead sponsor of 91 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 20 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Visiting grades 7-9 of regular secondary schools in Bosnia and Herzegovina.

Exclusion criteria

Exclusion Criteria:

Not fulfilling inclusion criteria.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,500 participants (estimated)

Study arms

  • Experimental
    Intervention group

    The intervention group receives a school-based module taking about two hours delivered by medical students in the schools.

    Behavioral: Education Against Tobacco School-Based Intervention

  • No intervention
    Control group

Interventions

  • BehavioralEducation Against Tobacco School-Based Intervention
06

What researchers measure

Primary outcomes

  1. Smoking prevalence measured via questionnaire.

    Time frame: 12 months follow-up

Secondary outcomes

  1. Smoking onset: Difference in the number of new smokers at 12 months of follow-up who were not present at baseline

    Time frame: Baseline and 12 months

  2. Difference in the number of new non-smokers at 12 months of follow-up who were smoking at baseline

    Time frame: Baseline and 12 months

  3. Relevant differences due to the theory of planned behaviour between the two groups measured via questionnaire.

    Difference in attitude towards smoking between the two groups at 12 months follow-up measured via questionnaires.

    Time frame: Baseline and 12 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 13, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02731547
Lead sponsor
University of Giessen
Collaborators
University of Dhaka
Responsible party
Titus J. Brinker (cand. med. Titus J. Brinker, University of Giessen) — Principal investigator
First posted
Apr 7, 2016
Start date
May 2016
Primary completion
Jun 2018 (estimated)
Last update
Apr 13, 2016

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion